Coronary Thrombus TIMI Grade Clinical Classification

Known as: TIMG01, TIMI Thrombus Grade 
A standardized grading system developed by the Thrombolysis in Myocardial Infarction (TIMI) Study Group to detect the presence of, and to describe… (More)
National Institutes of Health

Related topics

Related topics

2 relations
CDISC Clinical Classification Category TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome.
OBJECTIVES The study objective was to validate a new high-sensitivity troponin I (hs-TnI) assay in a clinical protocol for… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced…
OBJECTIVES This study sought to develop a risk score predictive of bleeding in patients undergoing percutaneous coronary… (More)
Is this relevant?
2009
2009
Does Simplicity Compromise Accuracy in ACS Risk Prediction? A Retrospective Analysis of the TIMI and GRACE Risk Scores
BACKGROUND The Thrombolysis in Myocardial Infarction (TIMI) risk scores for Unstable Angina/Non-ST-elevation myocardial… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
BACKGROUND Monocyte chemoattractant protein-1 (MCP-1) is a chemokine responsible for the recruitment of monocytes to sites of… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary…
BACKGROUND The current standard of care for patients with non-ST-segment elevation acute coronary syndromes (ACS) includes… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial.
BACKGROUND Although intravenous glycoprotein IIb/IIIa inhibitors are beneficial in patients with acute coronary syndromes… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy.
OBJECTIVES We evaluated the ability of serum amyloid A (SAA), alone and in combination with a rapid qualitative assay for cardiac… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes : A TIMI 11A substudy
 
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.
BACKGROUND The Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial compared the efficacy and safety of… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
1990
Highly Cited
1990
Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction.
A series of 198 consecutive patients with acute myocardial infarction were prospectively studied before hospital discharge and… (More)
Is this relevant?